Related Experiment Video
Updated: Jan 21, 2026

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
Published on: June 13, 2025
Baseline health status and setting impacted minimal clinically important differences in COPD: an exploratory study.
Harma Alma1, Corina de Jong1, Danijel Jelusic2
1Department of General Practice and Elderly Care Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Minimal clinically important differences (MCIDs) for chronic obstructive pulmonary disease (COPD) health status questionnaires vary based on patient characteristics and study setting. Tailored MCIDs are needed for accurate interpretation of clinical trial results.
Area of Science:
- Pulmonary Medicine
- Clinical Research Methodology
- Health Outcomes Measurement
Background:
- Minimal clinically important differences (MCIDs) are crucial for interpreting clinical trial outcomes in chronic obstructive pulmonary disease (COPD).
- The dynamic nature and influencing factors of MCIDs are not well understood.
- Standardized MCIDs may not accurately reflect patient experiences across diverse settings.
Purpose of the Study:
- To investigate the impact of baseline score, study setting, and patient characteristics on MCIDs for health status in COPD.
- To determine how factors like gender, age, disease severity, and comorbidities influence MCID estimates.
- To compare MCID estimates between pulmonary rehabilitation and routine clinical practice settings.
Main Methods:
- Retrospective analysis of baseline and follow-up data from COPD Assessment Test (CAT), Clinical COPD Questionnaire (CCQ), and St. George's Respiratory Questionnaire (SGRQ).
- Calculation and comparison of anchor- and distribution-based MCID estimates across various patient subgroups and settings.
- Inclusion of 658 patients with 2,299 change score measurements.
Main Results:
- MCID estimates varied significantly across subgroups, ranging from 0.50-6.30 for CAT, 0.10-0.84 for CCQ, and 0.33-12.86 for SGRQ.
- Worse baseline health status, female gender, older age, GOLD I/II classification, and fewer comorbidities were associated with larger improvement MCIDs and smaller deterioration MCIDs.
- Pulmonary rehabilitation settings yielded larger MCID estimates compared to routine clinical practice.
Conclusions:
- Baseline health status and study setting significantly influence MCID estimates for COPD health status questionnaires.
- Observed patterns related to gender, age, spirometry classification, and comorbidity levels highlight the need for individualized MCIDs.
- Tailored MCIDs are essential for precise interpretation of health status changes in COPD patients.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Impact of Groups on Groups
Difference from Background: Limit of Detection
The LOD indicates the presence or absence...
Electric Potential and Potential Difference
When a test charge moves from the initial to the final position, the electric potential difference between those positions is defined as the ratio of the change in the potential energy to the charge on the...

